Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

SDR16C6 Inhibitors

SDR16C6 inhibitors are chemical compounds that interact with the short-chain dehydrogenase/reductase family member 16C6 (SDR16C6), a specific enzyme categorized within the large superfamily of short-chain dehydrogenase/reductases (SDRs). SDR16C6, like other members of the SDR family, plays a pivotal role in various metabolic processes involving the reduction or oxidation of small molecules, including steroids, retinoids, and lipid substrates. Inhibitors of SDR16C6 disrupt its enzymatic activity, impeding the enzyme's ability to catalyze the redox reactions integral to these metabolic pathways. This inhibition can result from direct binding of the inhibitor to the enzyme's active site or via allosteric modulation, where binding occurs at a different site that leads to conformational changes. The specificity of these inhibitors for SDR16C6 can vary, and this specificity is often dictated by the inhibitor's molecular structure, which aligns with the unique binding domains of the enzyme.

At a molecular level, SDR16C6 inhibitors exhibit a diverse range of structural features, often including hydrophobic and polar regions that interact with critical residues in the enzyme's active or regulatory sites. These inhibitors may mimic natural substrates of SDR16C6, acting as competitive inhibitors, or they may induce non-competitive inhibition through interactions that alter the enzyme's conformation without directly competing with substrate molecules. The nature of inhibition-whether reversible or irreversible-depends on the chemical structure of the inhibitor and the type of bond formation involved. Characterization of these inhibitors involves a combination of techniques, including enzymatic assays, crystallographic studies, and computational modeling to understand the enzyme-inhibitor complex and the underlying binding dynamics. SDR16C6 inhibitors thus represent a fascinating area of study in enzyme kinetics and metabolic regulation due to their ability to precisely modulate enzyme activity at a molecular level.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Metformin

657-24-9sc-507370
10 mg
$79.00
2
(0)

May influence metabolic pathways, potentially affecting SDR16C6-related processes.

Atorvastatin

134523-00-5sc-337542A
sc-337542
50 mg
100 mg
$257.00
$505.00
9
(1)

Specifically inhibits HMG-CoA reductase, used to lower cholesterol levels.

Fenofibrate

49562-28-9sc-204751
5 g
$41.00
9
(1)

Activates peroxisome proliferator-activated receptor alpha (PPARα), influencing lipid metabolism.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$53.00
$89.00
7
(1)

Inhibits acetaldehyde dehydrogenase, affecting alcohol metabolism.

Epalrestat

82159-09-9sc-218319
10 mg
$200.00
2
(1)

Specifically inhibits aldose reductase, studied in the research of diabetic complications.

Pioglitazone

111025-46-8sc-202289
sc-202289A
1 mg
5 mg
$55.00
$125.00
13
(1)

A thiazolidinedione that activates PPARγ, used in diabetes management.

Nicotinamide riboside

1341-23-7sc-507345
10 mg
$411.00
(0)

A precursor of NAD+, potentially supporting dehydrogenase/reductase activity.

AICAR

2627-69-2sc-200659
sc-200659A
sc-200659B
50 mg
250 mg
1 g
$65.00
$280.00
$400.00
48
(2)

An AMPK activator, used to study metabolic processes.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

A sirtuin activator, potentially influencing dehydrogenase/reductase activity.